跳至主要内容
临床试验/NCT00979615
NCT00979615已完成4 期

Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis

Alcon Research1 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
129
试验地点
1
主要终点
Mean Change in 2-week rTNSS From Baseline

研究概览

简要总结

The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of VMR with at least 2 years of chronic non-allergic rhinitis
  • Negative skin tests to a panel of allergens and positive histamine test within last 2 years
  • History of symptoms related to defined VMR triggers

排除标准

  • Nasal disorder, surgery, or concurrent disease that could interfere with evaluation of study medications
  • Bacterial or viral infection within 14 days of first visit. Diagnosis of acute sinusitis within 30 days of first visit
  • Chronic use of drugs that can cause rhinitis

研究组 & 干预措施

1

Experimental

Olopatadine HCL Nasal Spray, 0.6%

干预措施: Olopatadine HCL (Patanase) Nasal Spray, 0.6% (Drug)

2

Active Comparator

Azelastine HCl Nasal Spray, 137 mcg

干预措施: Azelastine HCl (Astelin) Nasal Spray, 137 mcg (Drug)

结局指标

主要结局

Mean Change in 2-week rTNSS From Baseline

时间窗: 2 week

Change from baseline after 2 weeks in responses to patient-completed diaries for reflective Total Nasal VMR Symptom Scores (rTVSS). TVSS is composed of 4 individual assessments, which included nasal congestion, rhinorrhea, post nasal drip and sneezing; each of the 4 assessments were rated using a 4 point scale that ranged in whole units from 0 (none) to 3 (severe). All 4 assessments are totaled for a composite score (TVSS score), the maximum of which could be 12. Reflective scores were assessed from the hour since the last dose of study medication.

次要结局

  • Mean Change in Rhinorrhea Reflective Score(2 week)
  • Mean Change Postnasal Drip Reflective Score(2 Weeks)
  • Mean Change Nasal Congestion Reflective Score(2 Weeks)
  • Mean Change in Sneezing Reflective Score(2 Weeks)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验